Viracta Therapeutics, Inc. (VIRX)
NASDAQ: VIRX · Real-Time Price · USD
0.162
-0.005 (-2.82%)
Jan 22, 2025, 12:56 PM EST - Market open
Viracta Therapeutics Market Cap
Viracta Therapeutics has a market cap or net worth of $6.49 million as of January 22, 2025. Its market cap has decreased by -72.23% in one year.
Market Cap
6.49M
Enterprise Value
2.19M
1-Year Change
-72.23%
Ranking
Category
Stock Price
$0.16
Market Cap Chart
Since February 25, 2021, Viracta Therapeutics's market cap has decreased from $8.68M to $6.49M, a decrease of -25.21%. That is a compound annual growth rate of -7.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2025 | 6.63M | 3.60% |
| Dec 31, 2024 | 6.39M | -70.95% |
| Dec 29, 2023 | 22.02M | -60.52% |
| Dec 30, 2022 | 55.77M | -59.05% |
| Dec 31, 2021 | 136.19M | 1,468.41% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |